Gsk Plc · LSE:GSK

Gsk — GlaxoSmithKline — Investor Presentation (May 2015)

11 slides from Gsk's investor presentation, May 2015

  1. Slide 1: GlaxoSmithKline Aiken Factory Capabilities

    1 GlaxoSmithKline Aiken Factory Capabilities

  2. Slide 2: GSK Aiken

    GSK Aiken •Site Overview •Key Strengths •Capabilities •Capacity Utilization Page 2

  3. Slide 3: Site Overview

    Site Overview Facilities 250,000 sq. ft. Structure 43 acres owned • OTC Manufacturing and Packaging Facility, established in 1978. • 13 Consumer Brands and over 125 SKUs currently produced. • Global supplier to 56 different Countries. • Multiple successful Rx to OTC switches Page 3

  4. Slide 4: Markets Currently Supplied by Aiken

    Markets Currently Supplied by Aiken 70 new SKUs supplied in 56 countries the past 2 years supplied Page 4

  5. Slide 5: Who are we regulated by?

    Who are we regulated by? Page 5

  6. Slide 6: Key Strengths

    Key Strengths Quality and Compliance – a history of successful audits from multiple international regulatory agencies, including FDA, EMA, GCC, and ANVISA. Safety – a proactive, behavioral based safety program providing associates an environment where they leave work they same way they came. Custome

  7. Slide 7: Manufacturing Capabilities

    Manufacturing Capabilities Manufacturing High Shear Wet Granulation Continuous Wet Granulation Top Spray Granulation Extrusion Spheronization Fluid Bed Drying Powder Blending Tablet Compression Encapsulation Functional (Enteric) Coating Aqueous Film Coating Solution Manufacturing Page 7

  8. Slide 8: Packaging Capabilities

    Packaging Capabilities Packaging Primary Blister Pack -Foil to Foil, PVC/PVDC, Aclar Bottle Filling -20 to 250 cc Desiccant Filling Vial Filling/Packaging Neckbanding Pressure Roll Labeling Shrink Labeling OCR Vision Systems 2D Bar coding Check weighing Carton Packaging -Literature Page 8 and Bonus

  9. Slide 9: Laboratory Capabilities

    Laboratory Capabilities Quality and Analytical HPLC (Variable UV and Refractive index detectors) and GC (FID) Dissolution via USP/EP Apparatus 1, 2 and 3 Spectroscopy by UV/Visible, FTIR, and handheld Raman ID systems Atomic Absorption Spectroscopy Total Organic Carbon Analysis Laser Diffraction Par

  10. Slide 10: Aiken's Capacity Utilization

    Aiken’s Capacity Utilization Dose Form Group Production Stage Site Resource Group 2013 2014 2015 Tablet & Capsule Granulation (high sheer) Granulator/Fluid Bed Dryer 11 11 11 Capsule Encapsulation Encapsulator 14 14 14 Lozenge Granulation (continuous) MMG Train 46 44 42 Lozenge Blending/Compression

  11. Slide 11: What can GSK Aiken do for you?

    What can GSK Aiken do for you? GSK Aiken can provide you with a source of supply that is compliant, cost effective, and customer service oriented. Additionally, we offer a safe work environment for our associates, and our sustainability programs make us environmentally friendly. To further explore w

GlaxoSmithKline — Investor Presentation (May 2015) on 6ix